COAG

Conviction 23HealthcareScan · Mon, Jul 20, 2026

COAG$49.45+0.32%

ResistanceSupportVol 14Insider buy

Vol MA14 330.2K

May 1May 18Jun 2Jun 17Jul 2Jul 20

Hemab Therapeutics Holdings, Inc.Biotechnologywww.hemab.com ↗

Price49.45

Change+0.32%

Gap+3.53%

Rel volume1.23×

Avg volume313.97K

Avg $ vol11.63M

SMA 2036.33

SMA 5030.51

SMA 200—

Price vs 50+62.09%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 37.61

RSI (14)78

MACD hist1.57

MACD cross—

Stoch %K / %D88 / 93

ADX (14)34

+DI / −DI38 / 7

RSI divergence—

MACD divergence—

ATR %+7.81%

ADR %11.25%

52w high49.45

52w low24.98

From 52w high+0.00%

Above 52w low+97.96%

New 52w highYes

SqueezeOff

Bollinger width71.84%

%B1.00

Donchian pos89.08%

Donchian high52.15

Donchian low27.47

AVWAP (52w high)49.73

vs AVWAP high-0.56%

AVWAP (52w low)31.72

vs AVWAP low+55.89%

OBV trendUp

Chaikin MF (20)0.14

Today vs 20d1.23×

Avg vol (14d)330.2K

Avg vol (20d)313.97K

Avg $ vol (20d)11.63M

Market cap2.31B

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highYes

Trend template—

Technical rank98.5

1 week+25.16%

1 month+86.96%

3 months—

6 months—

1 year—

YTD+45.44%

P/E—

P/B-11.63

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current12.85

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target50.00

Target upside1.11%

Analyst ratingBuy

Institutional—

Ent. value2.26B

Revenue—

Net income-22.69M

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out46.71M

Employees—

ListedFri, May 1, 2026

Free float15.97M

Float %40.7%

Short interest1.71M

Days to cover4.0d

Short volume84.4%

Squeeze score65 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$23.98

Last surprise—

Setup gradeD

Conviction23 / 100

Pattern quality—

Tech rank98.5 / 100

Group rank23 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance35.42

Support24.15

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in COAG

All disclosures →

No recent disclosed trades by Congress in COAG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in COAG · 7 buys

Insider	Side	Shares	Value	Traded	Filed
RA Capital Healthcare Fund LP 10% owner · Common Stock · 2026-05-20	Buy	996	$25K	2026-05-20	2026-05-21
RA CAPITAL MANAGEMENT, L.P. 10% owner · Common Stock · 2026-05-20	Buy	996	$25K	2026-05-20	2026-05-21
Kolchinsky Peter 10% owner · Common Stock · 2026-05-20	Buy	996	$25K	2026-05-20	2026-05-21
Shah Rajeev M. 10% owner · Common Stock · 2026-05-20	Buy	996	$25K	2026-05-20	2026-05-21
RA Capital Healthcare Fund LP 10% owner · Common Stock · 2026-05-19	Other	—	—	2026-05-19	2026-05-21
Shah Rajeev M. 10% owner · Common Stock · 2026-05-19	Buy	3.8K	$95K	2026-05-19	2026-05-21
RA Capital Healthcare Fund LP 10% owner · Common Stock · 2026-05-19	Buy	3.8K	$95K	2026-05-19	2026-05-21
RA CAPITAL MANAGEMENT, L.P. 10% owner · Common Stock · 2026-05-19	Buy	3.8K	$95K	2026-05-19	2026-05-21
RA CAPITAL MANAGEMENT, L.P. 10% owner · Common Stock · 2026-05-19	Other	—	—	2026-05-19	2026-05-21
Shah Rajeev M. 10% owner · Common Stock · 2026-05-19	Other	—	—	2026-05-19	2026-05-21

SEC filings

EDGAR filings in COAG

EDGAR →

No recent SEC filings on file for COAG.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.